Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Philip P. Boudreau

At a glance: Philip P. Boudreau is CFO at Abbott Laboratories (ABT). Their latest SEC Form 4, filed Apr 27, 2026, reported a purchase of $201K. On file: 1 purchase line ($201K) and 0 sale lines ($0).

Disclosed holdings: about $229K of ABT stock: 2,200 shares (including shares held indirectly, e.g. through a trust or fund) reported on their latest Form 4 (filed Apr 27, 2026), valued at the Nov 20, 2026 close of $104.17. This counts only ABT shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

CFO at Abbott Laboratories (ABT)

Purchase track record

Not enough history. Based on 1 purchase with a full 90 days of price history.

—
Avg. 90-day return+13.4%
vs. S&P 500+9.8%
Beat the market100%
Paper profit on buys+$28K
Total bought / sold$201K / $0

Every purchase since 2026

From the SEC's insider data sets: each open-market buy by Philip P. Boudreau, matched to how the stock did over the next 90 days against the S&P 500.

1 of 1 buy beat the S&P 500 (100%), median +8.0% vs. the index. Small sample: treat with care. All insider buys: 46%.

StockFiled90 days vs. S&P 500
ABTApr 28, 2026+8.0%

Buys made close together in one stock count once. Price-only returns; history, not a prediction.

Reported trades

Filed Stock Type Shares Price Value Since
Apr 27SEC ABTAbbott LaboratoriesFirst buyNew position Buy 2,200new position $91.50 $201K +13.8%
  • Buy

    CFO Philip P Boudreau bought $201K of ABT at $91.50 — first open-market purchase in our records; opens a new position.

Follow Philip P. Boudreau

Get one email when Philip P. Boudreau files a new purchase or sale. Free.

At most one email a day about Philip P. Boudreau, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.